ARCHIVES

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

This article is from The Cancer Letter archive.

Vol. 16 No. 10 | March 9, 1990

Download PDF Visit The Full Archive

Related Articles

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

FDA Employee Inspired to Compose an Anthem for the Agency.

August 4, 2006

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004